Trial
NCT00194064
Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
Eli Lilly and Company
Condition
Bipolar Disorder
Intervention
Olanzapine
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-04